We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$91.9B
AUM Growth
-$622M
Cap. Flow
-$6.3B
Cap. Flow %
-6.85%
Top 10 Hldgs %
34.23%
Holding
7,315
New
572
Increased
2,784
Reduced
3,105
Closed
393

Sector Composition

Rank Sector Weight
1 Technology 5.74%
2 Healthcare 5.25%
3 Financials 4.26%
4 Communication Services 3.9%
5 Consumer Discretionary 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBT
5001
PUT
Permian Basin Royalty Trust
PBT
$1.38B
$75K ﹤0.01%
8,000
+5,000
+167% +$44.6K
VNET
5002
PUT
VNET Group
VNET
$2.04B
$75K ﹤0.01%
13,700
-32,200
-70% -$218K
FNHC
5003
DELISTED
FedNat Holding Company Common Stock
FNHC
$75K ﹤0.01%
4,338
+3,831
+756% +$72.9K
AXAS
5004
DELISTED
Abraxas Petroleum Corp
AXAS
$75K ﹤0.01%
+1,875
New +$85.7K
CPAAU
5005
DELISTED
Conyers Park Acquisition Corp. Unit
CPAAU
$75K ﹤0.01%
6,762
DCOM
5006
DELISTED
Dime Community Bancshares
DCOM
$75K ﹤0.01%
3,713
+3,192
+613% +$66.4K
ATI icon
5007
CALL
ATI
ATI
$25.6B
$74K ﹤0.01%
4,100
-25,400
-86% -$477K
EUO icon
5008
PUT
ProShares UltraShort Euro
EUO
$34.7M
$74K ﹤0.01%
2,800
-4,000
-59% -$106K
FFIC
5009
DELISTED
Flushing Financial
FFIC
$74K ﹤0.01%
2,791
+1,609
+136% +$44.9K
MBWM icon
5010
Mercantile Bank Corp
MBWM
$1.04B
$74K ﹤0.01%
2,143
+1,600
+295% +$53.9K
UMC icon
5011
United Microelectronic
UMC
$47.7B
$74K ﹤0.01%
38,200
-55,700
-59% -$106K
JBTM
5012
JBT Marel
JBTM
$7.21B
$74K ﹤0.01%
836
-114
-12% -$9.88K
KS
5013
PUT
DELISTED
KapStone Paper and Pack Corp.
KS
$74K ﹤0.01%
3,200
-1,600
-33% -$36.9K
FTK icon
5014
CALL
Flotek Industries
FTK
$852M
$73K ﹤0.01%
950
+550
+138% +$37.7K
GIL icon
5015
CALL
Gildan
GIL
$10.3B
$73K ﹤0.01%
+2,700
New +$68.8K
NBTB icon
5016
NBT Bancorp
NBTB
$2.74B
$73K ﹤0.01%
1,972
+1,305
+196% +$52.6K
RDUS
5017
CALL
DELISTED
Radius Health, Inc.
RDUS
$73K ﹤0.01%
1,900
+1,100
+138% +$46.1K
SBBP
5018
DELISTED
Strongbridge Biopharma plc.
SBBP
$73K ﹤0.01%
+15,314
New +$46.9K
MXWL
5019
DELISTED
Maxwell Technologies Inc
MXWL
$73K ﹤0.01%
12,429
+12,293
+9,039% +$63.2K
OME
5020
DELISTED
Omega Protein
OME
$73K ﹤0.01%
3,630
+177
+5% +$4.12K
RVLT
5021
DELISTED
Revolution Lighting Technologies, Inc. - Class A
RVLT
$73K ﹤0.01%
+9,792
New +$64.8K
BCRX icon
5022
PUT
BioCryst Pharmaceuticals
BCRX
$2.28B
$72K ﹤0.01%
8,600
+6,700
+353% +$46.6K
CINF icon
5023
CALL
Cincinnati Financial
CINF
$27.3B
$72K ﹤0.01%
1,000
-600
-38% -$43.5K
CULP icon
5024
Culp Inc
CULP
$44.1M
$72K ﹤0.01%
2,308
+2,272
+6,311% +$74.9K
DXD icon
5025
CALL
ProShares UltraShort Dow 30
DXD
$42.2M
$72K ﹤0.01%
280
-385
-58% -$102K

Similar funds

Barclays's Q1 2017 Portfolio in Review

As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Barclays withdrew a net $6.3B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.

  • Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
  • Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
  • Barclays's biggest Q1 2017 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $380M.
  • Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
  • Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
  • Barclays opened 572 new positions and closed 393 in Q1 2017.
  • Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.

Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.